Jan 13, 2017------News Archive—Latest research covered daily, archived weekly
New hope for Prader-Willi syndrome
Duke Health researchers have identified a drug-like small molecule that, in animal experiments, appears to be an effective treatment for a genetic disorder called Prader-Willi syndrome. Studies in mice and human cell lines indicate other gene-based diseases might also benefit.
Jan 12, 2017-----News Archive—Latest research covered daily, archived weekly
Early trial results shrink pediatric neural tumors
In a clinical trial of selumetinib, a new oral drug, children with the genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tolerated selumetinib with most experiencing shrinkage of their tumors. NF1 affects 1 in 3,000 people.
Jan 11, 2017------News Archive—Latest research covered daily, archived weekly
Targeting pre-malignant bone marrow cancers
Mechanisms that create healthy red blood cells may also target blood disorders such as myelodysplasia (MDS) syndromes. MDS blood disorders are pre-malignant. In each, bone marrow stops producing adequate numbers of healthy blood cells. Knowing the how and why of blood cell formation has given us a clue to possible ways to interrupt these disorders.
Jan 10, 2017------News Archive—Latest research covered daily, archived weekly
Missing protein may explain Sudden Infant Death
A protein originally discovered at The Scripps Research Institute (TSRI) appears to monitor lung volume and regulate our breathing, according to a new study led by scientists at TSRI and Harvard Medical School.
Jan 9, 2017------News Archive—Latest research covered daily, archived weekly
Brain's facial recognition area grows in adulthood
Our ability to recognize faces improves from infancy to adulthood. Facial recognition grows a part of our brain to record specific facial features to our visual system.